Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Press Releases
Donate Now
MJFF in the News

Press Releases

Browse current and past press releases from The Michael J. Fox Foundation.

 From
To
  • Default content image

    The Michael J. Fox Foundation Forms New Partnership with The Bachmann-Strauss Dystonia and Parkinson's Foundation

    The Michael J. Fox Foundation for Parkinson's Research (MJFF) and The Bachmann-Strauss Dystonia and Parkinson Foundation (BSDPF) announced today a new collaborative research alliance to facilitate…
    Learn more
  • Default content image

    Survey Reveals Knowledge Gaps Among Parkinson's Patients and Caregivers

    NEW YORK, NY, September 9, 2014 - A recent survey of more than 1,500 Parkinson's disease (PD) patients, caregivers and physicians reveals that information and specialized care can help…
    Learn more
  • Default content image

    The Michael J. Fox Foundation and Intel Join Forces to Improve Parkinson's Disease Monitoring and Treatment through Advanced Technologies

    The Michael J. Fox Foundation for Parkinson's Research (MJFF) and Intel Corporation announced today a collaboration aimed at improving research and treatment for Parkinson's disease -- a…
    Learn more
  • Default content image

    Promising Parkinson's Disease Research Highlighted by The Michael J. Fox Foundation to Accelerate Drug Development

    Research projects from five groups active in Parkinson's research comprise the 2014 first half (1H 2014) of The Michael J. Fox Foundation for Parkinson's Research (MJFF) Partnering Program. Among the…
    Learn more
  • Default content image

    To Inform or Not to Inform? That Is the Question for Genetics Researchers

    Researchers need to know the genetic profiles of their study participants to understand more about how certain mutations manifest disease. But do the participants have to know?A group of 35 Parkinson…
    Learn more
  • Default content image

    First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development

    NEW YORK and  VIENNA, Austria - AFFiRiS AG announced today at a press conference in New York results of AFF008, a Phase I clinical trial of PD01A, a vaccine against Parkinson's disease. PD01A is…
    Learn more
  • Default content image

    RaceTrac Reaches $1 Million Milestone in Giving to The Michael J. Fox Foundation for Parkinson's Research

    Atlanta, GA - July 28, 2014 -RaceTrac announced that its cumulative giving to The Michael J. Fox Foundation for Parkinson's Research has exceeded $1 million. This milestone is due in large part to…
    Learn more
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.